JACOBS LEVY EQUITY MANAGEMENT, INC - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 240 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2023. The put-call ratio across all filers is 2.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$18,765,773
-2.2%
1,428,141
-6.2%
0.11%0.0%
Q2 2023$19,180,489
-9.2%
1,522,261
-6.0%
0.11%
-14.6%
Q1 2023$21,131,578
-22.7%
1,619,278
+4.5%
0.13%
-29.7%
Q4 2022$27,341,965
+12.9%
1,549,998
-2.5%
0.18%
-3.1%
Q3 2022$24,219,000
-30.0%
1,590,205
-31.9%
0.19%
-28.7%
Q2 2022$34,623,000
-37.5%
2,334,689
-5.0%
0.27%
-28.0%
Q1 2022$55,358,000
+39.1%
2,458,152
+14.0%
0.37%
+39.8%
Q4 2021$39,788,000
+31.6%
2,156,527
-4.6%
0.27%
+30.4%
Q3 2021$30,237,000
-35.3%
2,261,573
-10.4%
0.20%
-35.6%
Q2 2021$46,741,000
+37.5%
2,525,192
+11.5%
0.32%
+21.0%
Q1 2021$33,999,000
+1.1%
2,264,341
-2.8%
0.26%
-11.2%
Q4 2020$33,633,000
+57.7%
2,329,165
-11.1%
0.30%
+33.5%
Q3 2020$21,328,000
+16.8%
2,620,091
-2.9%
0.22%
+11.6%
Q2 2020$18,263,000
-10.9%
2,697,708
-7.4%
0.20%
-24.7%
Q1 2020$20,500,000
-21.4%
2,911,956
+9.6%
0.26%
+2.7%
Q4 2019$26,069,000
+6.1%
2,656,085
+18.7%
0.26%
-15.2%
Q3 2019$24,569,000
+44.4%
2,237,636
+53.0%
0.30%
+28.5%
Q2 2019$17,009,000
+24.2%
1,462,549
+1.9%
0.24%
+18.7%
Q1 2019$13,697,000
+5.8%
1,435,739
+6.9%
0.20%
-13.2%
Q4 2018$12,950,000
-41.1%
1,343,339
-13.0%
0.23%
-26.9%
Q3 2018$21,998,000
+12.0%
1,543,688
-5.7%
0.31%
+1.0%
Q2 2018$19,647,000
+12.5%
1,637,243
+15.8%
0.31%
+6.2%
Q1 2018$17,465,000
-10.9%
1,414,143
+4.9%
0.29%
-15.7%
Q4 2017$19,610,000
+27.7%
1,347,743
+24.9%
0.34%
+15.8%
Q3 2017$15,355,000
+48.0%
1,079,043
+32.8%
0.30%
+34.2%
Q2 2017$10,372,000
+108.1%
812,819
+106.8%
0.22%
+119.8%
Q1 2017$4,984,000
-10.0%
393,077
-27.6%
0.10%
-5.6%
Q4 2016$5,540,000
-18.4%
542,568
+5.2%
0.11%
-11.6%
Q3 2016$6,790,000
+60.4%
515,568
+54.7%
0.12%
+37.5%
Q2 2016$4,233,000
-59.8%
333,300
-58.2%
0.09%
-60.5%
Q1 2016$10,521,000
+75.0%
796,477
+103.7%
0.22%
+87.4%
Q4 2015$6,013,000
+108.7%
390,940
+68.2%
0.12%
+101.7%
Q3 2015$2,881,000
+151.8%
232,370
+177.8%
0.06%
+168.2%
Q2 2015$1,144,000
+15.9%
83,650
+1.3%
0.02%
+29.4%
Q1 2015$987,000
+25.6%
82,550
+41.0%
0.02%
+30.8%
Q3 2014$786,00058,5600.01%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q1 2023
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders